← Open Payments lookup

MELISSA DENNY: Open Payments

NPI 1902548480 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,541 in 43 payments from 14 companies in 2025. Trend: 2023 $14 · 2024 $1,450 · 2025 $1,541

Food & beverage: $1,541
CompanyPaymentsAmount
Amgen Inc.5$240
Merck Sharp & Dohme LLC8$237
Travere Therapeutics, Inc.4$202
Novo Nordisk Inc4$172
AstraZeneca Pharmaceuticals LP3$151
Calliditas Therapeutics US Inc.6$132
Vifor Pharma, Inc.1$125
Otsuka America Pharmaceutical, Inc.3$71
Ardelyx, Inc.2$59
Takeda Pharmaceuticals U.S.A., Inc.2$48

Products named: PREVYMIS, Ozempic, TARPEYO, LOKELMA, Filspari, Veltassa, TAVNEOS, KRYSTEXXA.

Industry payments across TX — which companies pay providers there.